Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Mark Chiu, PhD
Co-founder - Entrepreneur at Qilin Glen LLC
Speaker

Agenda Sessions

  • Promising Clinical Profiles of TAVO412, a Trispecific EGFR x cMET x VEGF antibody, in Patients with Multiple Solid Tumors

    , 10:00
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Mark at Antibody Engineering & Therapeutics Europe